BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30605717)

  • 1. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.
    Saini S; Maker AV; Burman KD; Prabhakar BS
    Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188262. PubMed ID: 30605717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
    Smith N; Nucera C
    J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.
    Weinberger P; Ponny SR; Xu H; Bai S; Smallridge R; Copland J; Sharma A
    Thyroid; 2017 Feb; 27(2):236-252. PubMed ID: 27796151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
    Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG
    Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
    Latteyer S; Tiedje V; König K; Ting S; Heukamp LC; Meder L; Schmid KW; Führer D; Moeller LC
    Endocrine; 2016 Dec; 54(3):733-741. PubMed ID: 27696251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer.
    Sasanakietkul T; Murtha TD; Javid M; Korah R; Carling T
    Mol Cell Endocrinol; 2018 Jul; 469():23-37. PubMed ID: 28552796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
    Bonhomme B; Godbert Y; Perot G; Al Ghuzlan A; Bardet S; Belleannée G; Crinière L; Do Cao C; Fouilloux G; Guyetant S; Kelly A; Leboulleux S; Buffet C; Leteurtre E; Michels JJ; Tissier F; Toubert ME; Wassef M; Pinard C; Hostein I; Soubeyran I
    Thyroid; 2017 May; 27(5):682-692. PubMed ID: 28351340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.
    Egan CE; Stefanova D; Ahmed A; Raja VJ; Thiesmeyer JW; Chen KJ; Greenberg JA; Zhang T; He B; Finnerty BM; Zarnegar R; Jin MM; Scognamiglio T; Dephoure N; Fahey T; Min IM
    Thyroid; 2021 Oct; 31(10):1481-1493. PubMed ID: 34078123
    [No Abstract]   [Full Text] [Related]  

  • 10. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
    Kasaian K; Wiseman SM; Walker BA; Schein JE; Zhao Y; Hirst M; Moore RA; Mungall AJ; Marra MA; Jones SJ
    BMC Cancer; 2015 Dec; 15():984. PubMed ID: 26680454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network analysis reveals essential proteins that regulate sodium-iodide symporter expression in anaplastic thyroid carcinoma.
    Rakhsh-Khorshid H; Samimi H; Torabi S; Sajjadi-Jazi SM; Samadi H; Ghafouri F; Asgari Y; Haghpanah V
    Sci Rep; 2020 Dec; 10(1):21440. PubMed ID: 33293661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
    Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
    J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
    Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
    Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines.
    Woodward EL; Biloglav A; Ravi N; Yang M; Ekblad L; Wennerberg J; Paulsson K
    Endocr Relat Cancer; 2017 May; 24(5):209-220. PubMed ID: 28235956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of
    Ibrahimpasic T; Xu B; Landa I; Dogan S; Middha S; Seshan V; Deraje S; Carlson DL; Migliacci J; Knauf JA; Untch B; Berger MF; Morris L; Tuttle RM; Chan T; Fagin JA; Ghossein R; Ganly I
    Clin Cancer Res; 2017 Oct; 23(19):5970-5980. PubMed ID: 28634282
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.
    Wang P; Shang J; Zhao J; Wang K; Guo L; Gu J; Wang W
    Mol Med Rep; 2020 Mar; 21(3):1201-1207. PubMed ID: 31922212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
    Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
    Yoo SK; Song YS; Lee EK; Hwang J; Kim HH; Jung G; Kim YA; Kim SJ; Cho SW; Won JK; Chung EJ; Shin JY; Lee KE; Kim JI; Park YJ; Seo JS
    Nat Commun; 2019 Jun; 10(1):2764. PubMed ID: 31235699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.